Page 179 - FBL AR 2019-20

CORPORATE STATUTORY FINANCIAL
OVERVIEW STATEMENTS STATEMENTS

Consolidated Statement of Profit and Loss for the year ended March 31, 2020
( H in Lakhs )
Notes March 31, 2020 March 31, 2019*
Income:
Revenue from operations 33 29,294.92 40,467.04
Other income 34 1,232.30 1,236.52
Total Income 30,527.22 41,703.56
Expenses:
Cost of materials consumed 35 10,561.26 10,320.06
Purchases of stock-in-trade 50.15 187.54
Changes in inventories of finished goods, stock-in-trade and work-in-progress 36 (2,708.90) (1,282.35)
Employee benefits expense 37 5,003.15 5,317.79
Finance costs 38 1,914.04 2,065.31
Depreciation and amortisation expense 39 1,499.97 1,188.75
Other expenses 40 9,865.54 11,035.85
Total expenses 26,185.21 28,832.95
Profit before tax 4,342.01 12,870.61
Tax expense:
Current tax 64 338.88 3,195.65
Deferred tax credit 59C & 64 (1,948.89) (2,115.30)
Total tax expense (1,610.01) 1,080.35
Profit for the year before share of loss of associates and a joint venture 5,952.02 11,790.26
- Share of loss of associates - (49.82)
- Share of profit / (loss) of a joint venture - 7.04
Profit for the year 5,952.02 11,747.48
Other comprehensive income:
Items that will not be reclassified to profit or loss
a) (i) Remeasurements of defined benefit plan 240.63 (186.51)
(ii) Income tax relating to remeasurements of defined benefit plan (70.07) 35.33
b) Net fair value change in investment in equity instruments through other comprehensive 11.34 2.57
income
Items that will be reclassified to profit or loss
Exchange differences in translating the financial statements of foreign operations (8.33) -
Total other comprehensive income / (loss) for the year (a+b) 173.57 (148.61)
Total comprehensive income for the year 6,125.59 11,598.87
Profit for the year attributable to:
- Owners of the Company 5,952.60 11,745.32
- Non-controlling interests (0.58) 2.16
5,952.02 11,747.48
Total other comprehensive income / (loss) for the year
- Owners of the Company 173.57 (148.61)
- Non-controlling interests - -
173.57 (148.61)
Total comprehensive income for the year attributable to:
- Owners of the Company 6,126.17 11,596.71
- Non-controlling interests (0.58) 2.16
6,125.59 11,598.87
Earnings per equity share of H5 each (Post bonus) 22 (c) & 41
Basic (in H) 20.63 40.72
Diluted (in H) 20.53 40.70
*(Refer note 1.2)
See accompanying notes 1 to 69 to the Consolidated financial statements
In terms of our report attached
For DELOITTE HASKINS & SELLS LLP For and on behalf of the Board of Directors of
Chartered Accountants Fermenta Biotech Limited (Formerly known as DIL Limited)

Rajesh K. Hiranandani Krishna Datla Satish Varma Prashant Nagre
Partner Managing Director Executive Director Chief Executive Officer

Sumesh Gandhi Srikant N. Sharma
Chief Financial Officer Company Secretary

Mumbai, August 28, 2020 Thane, August 28, 2020

177